A recent Roadrunner call shows the importance of knowing when to sell. Read More
Jim Fink is chief investment strategist for Options for Income, Velocity Trader, and Jim Fink's Inner Circle. He has traded options for more than 30 years and generated personal profits of more than $5 million. Jim also serves as an investment analyst at Investing Daily’s flagship investing publication, Personal Finance.
Hopelessly overeducated, Jim holds a bachelor's degree from Yale University, a master's degree from Harvard's Kennedy School of Government, a law degree from Columbia University, and an MBA from the University of Virginia's Darden School of Business. For good measure, he has been a member of the Illinois and D.C. bars.
Prior to joining Investing Daily, and when not incurring student loans hiding out in academe, Jim practiced telecommunications regulatory law for nine years until he realized that he made more money trading stock options than writing briefs. After attending business school, Jim switched gears to the investment realm full-time, working for a university endowment, a private wealth management firm, an insurance and financial planning company, and as a Senior Analyst for an online investment newsletter service that encourages the wearing of funny hats.
A possible but unlikely descendant of legendary brawler and boatman Mike Fink, Jim defies his heritage, believing that investing success requires patience and analysis, not swashbuckling bravado. Besides his passion for analyzing and writing about stocks, Jim likes to hike in the desert Southwest, vacation in Las Vegas, play tennis, and feed his toddler son Cheerios.
Analyst Articles
G-III Apparel keeps its winning streak alive. Read More
It's not yet time yet to turn bearish on stocks. Read More
In the August issue of Roadrunner Stocks, four new BUY recommendations and four SELL recommendations have been issued. 1. The Value Portfolio is adding energy-service firm RPC Inc. (RES) and selling electrical component contract manufacturer Fabrinet (FN).2. The Momentum Portfolio is adding:Human interface digital solutions… Read More
September may prove challenging for stocks, but the rally should resume soon afterwards. The new momentum stock-selection formula is starting to bear fruit. Serious fruit. Read More
Biotech stock United Therapeutics and apparel company G-III Apparel are exhibiting the best of both worlds: price momentum and reasonable valuations. Read More
The North American fracking environment is experiencing a cyclical upturn and this pure-play small cap on the fracking revolution has a long runway of potential growth to benefit directly from this trend. With management in the hands of an aging and dysfunctional family, a takeover may be in the company's future. Read More
A favorable court decision leads to a one-day jump of more than 28 percent. Read More
The recent trend toward buyouts of small-cap biotech companies. Read More
They don’t just grow your nest egg – they can prolong its life. Read More